Home » Topics » Regulatory » Patents

Patents
RSS

Estrogenic compounds from Sankyo

Aug. 30, 1996

Potent antiinflammatory/antioxidant agents from Alcon

Aug. 30, 1996

DNA cleaving reagents from the University of Cincinnati

Aug. 30, 1996

Superoxide ion production inhibitors from Sagami

Aug. 30, 1996

VLA-4 receptor-blocking drugs described by Zeneca

Aug. 30, 1996

Protease inhibitors described by Shionogi

Aug. 30, 1996

Antiherpes compounds from Bio-Mega/Boehringer Ingelheim

Aug. 30, 1996

Toyama reveals anti-HIV quinolones

Aug. 30, 1996

Tetromycin A: a novel antibacterial agent

Aug. 30, 1996

Antifungal agents from Hokko Kagaku

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...